Tiaprofenic acid: Difference between revisions
m (Protected "Tiaprofenic acid": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
No edit summary |
||
Line 1: | Line 1: | ||
{{Drugbox| | {{Drugbox | ||
|IUPAC_name = | | verifiedrevid = 470610046 | ||
| IUPAC_name = (''RS'')-2-(5-benzoyl-2-thienyl)propanoic acid | |||
| image = Tiaprofenic acid.svg | | image = Tiaprofenic acid.svg | ||
| | | width = 200 | ||
| | | imagename = 1 : 1 mixture (racemate) | ||
| | | drug_name = Tiaprofenic acid | ||
<!--Clinical data--> | |||
| | | tradename = | ||
| | | Drugs.com = {{drugs.com|CONS|tiaprofenic_acid}} | ||
| | |||
| | |||
| pregnancy_category = C | | pregnancy_category = C | ||
| legal_status = POM | | legal_status = POM | ||
| routes_of_administration= oral | | routes_of_administration = oral | ||
<!--Pharmacokinetic data--> | |||
| bioavailability = 90% | |||
| metabolism = 10% hepatic | |||
| elimination_half-life = 1.5-2.5h | |||
| excretion = 50-80% urine | |||
<!--Identifiers--> | |||
| CASNo_Ref = {{cascite|correct|CAS}} | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 33005-95-7 | |||
| ATC_prefix = M01 | |||
| ATC_suffix = AE11 | |||
| PubChem = 5468 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = DB01600 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 5269 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 1LS1T6R34C | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D01325 | |||
| ChEBI_Ref = {{ebicite|correct|EBI}} | |||
| ChEBI = 32221 | |||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | |||
| ChEMBL = 365795 | |||
<!--Chemical data--> | |||
| C=14 | H=12 | O=3 | S=1 | |||
| molecular_weight = 260.309 | |||
| smiles = O=C(c1sc(cc1)C(C(=O)O)C)c2ccccc2 | |||
| InChI = 1/C14H12O3S/c1-9(14(16)17)11-7-8-12(18-11)13(15)10-5-3-2-4-6-10/h2-9H,1H3,(H,16,17) | |||
| InChIKey = GUHPRPJDBZHYCJ-UHFFFAOYAF | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C14H12O3S/c1-9(14(16)17)11-7-8-12(18-11)13(15)10-5-3-2-4-6-10/h2-9H,1H3,(H,16,17) | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = GUHPRPJDBZHYCJ-UHFFFAOYSA-N | |||
| synonyms = <small>5-Benzoyl-α-methyl-2-thiopheneacetic acid</small> | |||
}} | }} | ||
'''Tiaprofenic acid''' is a [[non-steroidal anti-inflammatory drug]] of the arylpropionic acid (profen) class, used to treat pain, especially [[Arthritis|arthritic]] pain. The typical adult dose is | '''Tiaprofenic acid''' is a [[non-steroidal anti-inflammatory drug]] (NSAID) of the arylpropionic acid (profen) class, used to treat pain, especially [[Arthritis|arthritic]] pain. The typical adult dose is 300 mg twice daily. It is not recommended in children. | ||
It is sparingly metabolised in the [[liver]] to two inactive metabolites. Most of the drug is eliminated unchanged in the [[urine]]. Renal disease impairs excretion, and it should be used with caution in renal disease. | It is sparingly metabolised in the [[liver]] to two inactive metabolites. Most of the drug is eliminated unchanged in the [[urine]]. Renal disease impairs excretion, and it should be used with caution in renal disease. | ||
Long-term use of tiaprofenic acid is associated with severe [[cystitis]], roughly 100 times more commonly than other NSAIDs.<ref>{{cite journal | author = Crawford MLA, Waller PC, Wood SM | title = Severe cystitis associated with tiaprofenic acid | journal = British Journal of Urology | year = 1997 | volume = 79 | issue = 4 | pages = 578–584 | doi = 10.1046/j.1464-410X.1997.00094.x | pmid = 9126086}}</ref> It is contraindicated in patients with cystitis and urinary tract infections. | |||
It is marketed under the trade names '''Surgam''', '''Surgamyl''' and '''Tiaprofen''', and in [[Generic drug|generic]] formulations. A sustained-release preparation is available. | The earliest reports of clinical use are from France in 1975 <ref>{{cite journal | author = Pons J, Pasturel A | title = [How to improve postoperative complications in stomatological, maxillofacial and plastic surgery: evaluation of tiaprofenic acid]. [French] | journal = Revue d Odonto-Stomatologie. | year = 1975 | volume = 4 | issue = 6 pages = 535-7}}</ref> | ||
It is marketed under the trade names '''Surgam''', '''Surgamyl''' and '''Tiaprofen''', and in [[Generic drug|generic]] formulations. A sustained-release preparation is available. It is [[isomer]] with [[Suprofen]]. | |||
== References == | == References == | ||
{{reflist}} | |||
== External links == | == External links == | ||
* Manufacturer Data Sheet [http://www.medsafe.govt.nz/profs/Datasheet/s/Surgamtab.htm] | * Manufacturer Data Sheet [http://www.medsafe.govt.nz/profs/Datasheet/s/Surgamtab.htm]{{dead link|date=November 2011}} | ||
{{Anti-inflammatory and antirheumatic products}} | {{Anti-inflammatory and antirheumatic products}} | ||
[[ | {{DEFAULTSORT:Tiaprofenic Acid}} | ||
[[Category:Non-steroidal anti-inflammatory drugs]] | |||
[[Category:Aromatic ketones]] | |||
[[Category:Thiophenes]] | |||
{{musculoskeletal-drug-stub}} | |||
Revision as of 14:57, 13 April 2015
File:Tiaprofenic acid.svg | |
Clinical data | |
---|---|
Synonyms | 5-Benzoyl-α-methyl-2-thiopheneacetic acid |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy category |
|
Routes of administration | oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 90% |
Metabolism | 10% hepatic |
Elimination half-life | 1.5-2.5h |
Excretion | 50-80% urine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C14H12O3S |
Molar mass | 260.309 |
3D model (JSmol) | |
| |
| |
(verify) |
Tiaprofenic acid is a non-steroidal anti-inflammatory drug (NSAID) of the arylpropionic acid (profen) class, used to treat pain, especially arthritic pain. The typical adult dose is 300 mg twice daily. It is not recommended in children.
It is sparingly metabolised in the liver to two inactive metabolites. Most of the drug is eliminated unchanged in the urine. Renal disease impairs excretion, and it should be used with caution in renal disease.
Long-term use of tiaprofenic acid is associated with severe cystitis, roughly 100 times more commonly than other NSAIDs.[1] It is contraindicated in patients with cystitis and urinary tract infections.
The earliest reports of clinical use are from France in 1975 [2]
It is marketed under the trade names Surgam, Surgamyl and Tiaprofen, and in generic formulations. A sustained-release preparation is available. It is isomer with Suprofen.
References
- ↑ Crawford MLA, Waller PC, Wood SM (1997). "Severe cystitis associated with tiaprofenic acid". British Journal of Urology. 79 (4): 578–584. doi:10.1046/j.1464-410X.1997.00094.x. PMID 9126086.
- ↑ Pons J, Pasturel A (1975). "[How to improve postoperative complications in stomatological, maxillofacial and plastic surgery: evaluation of tiaprofenic acid]. [French]". Revue d Odonto-Stomatologie. 4 (6 pages = 535-7).
External links
- Pages with script errors
- CS1 maint: Multiple names: authors list
- CS1 maint: Missing pipe
- Pages with broken file links
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles with non-default infobox title
- All articles with dead external links
- Articles with dead external links from November 2011
- Articles with invalid date parameter in template
- Non-steroidal anti-inflammatory drugs
- Aromatic ketones
- Thiophenes